HCC Surveillance: Reevaluating the Evidence and Limitations
- 2 October 2026
- journal article
- letter
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (11) , 3677-3678
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The Impact of HCC Surveillance on Tumor Features and Receipt of Curative Therapy: A Focus on Chronic Hepatitis B and MASLDJournal of Gastroenterology and Hepatology, 2026
- Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)Annals of Hepatology, 2025
- The healthy user effect in pharmacoepidemiologyAmerican Journal of Epidemiology, 2024
- Metabolic dysfunction-associated steatotic liver disease and its link to cancerMetabolism, 2024